The US is communicating regularly with India in bilateral and multilateral channels to discuss the supply of Covid-19 vaccines and inquire about its timeline for restarting vaccine exports. “Vaccinating as much of the developing world, as quickly as possible, is in America’s vital interest, because the uncontrolled spread of the virus inevitably produces more dangerous variants,” an Axios report said.

The United States has been pushing India to restart vaccine exports as it looks to stem the global spread of the Covid pandemic.

The US is communicating regularly with India in bilateral and multilateral channels to discuss the supply of Covid-19 vaccines and inquire about its timeline for restarting vaccine exports, a senior Biden administration official told Reuters.

The supply of Covid vaccines will also be one of the key topics of discussion during the first in-person Quad leadership meeting in US on September 24. Quad is a multilateral alliance of US, India, Australia and Japan.

During their virtual meeting in March this year, the Quad leaders had agreed to work closely on boosting Covid-19 vaccine supply.

However, the initiative was stalled after India was struck by the deadly second wave of the virus.

Since then, India’s vaccine exports took a major hit as the country sought to prioritise immunisation of its population of over 1.3 billion people.

According to Axios, the Biden administration is now looking to push Modi to renew vaccine supply to the world through the global Covax initiative since it wants to mitigate the international spread of the virus.

“Vaccinating as much of the developing world, as quickly as possible, is in America’s vital interest, because the uncontrolled spread of the virus inevitably produces more dangerous variants,” the Axios report said.

“Washington was staying in close touch with India and other Quad partners about the vaccine partnership, and any factors that may affect this project or global vaccine supply, but those discussions were not tied to a specific summit or engagement,” the US official said.

The official noted that Washington had diverted its own supply of raw materials for vaccine production to India in April, given its urgent needs, and global vaccine supply remained a key bottleneck to ending the pandemic.

“We commend India for being one of the largest manufacturers for safe and effective COVID-19 vaccines globally, and we note that COVAX and the world rely heavily on India’s contributions,” the official said. “It’s important for the United States to engage all our allies and partners on these matters so we can take the necessary actions to end this pandemic together.“

However, while US is pushing India to kickstart its vaccine exports, it had stalled its own vaccine exports for months to prioritise shots for its population under the “America First” policy.

Reference: https://health.economictimes.indiatimes.com/news/pharma/why-us-is-pushing-india-to-restart-covid-vaccine-exports/86194407

More News
Continuous manufacturing (CM): A game changer for pharma
News · 01/12/2023

Why will CM be the next generation on quality?

READ MORE
ICCM5 adopts new framework
News · 31/10/2023

The Fifth International Conference on Chemicals Management (ICCM5) concluded on 30 September in Bonn, Germany, by adopting “a comprehensive global framework that sets concrete targets and guidelines for key sectors across the entire lifecycle of chemicals”.

READ MORE
The Global Impact Of China’s Golden Week: Is Your Business Ready?
News · 29/09/2023

In October, the People’s Republic of China celebrates its annual national holiday, known as Golden Week. Similar to Chinese New Year, the entire country is on holiday, resulting in business closures and a potential 14-day halt in production and transportation of manufactured goods.

READ MORE
ECHA Adds Five Hazardous Chemicals To PIC
News · 08/09/2023

The European Chemicals Agency (ECHA) has amended the Prior Informed Consent (PIC) Regulation, EU 64/2012, to add 27 pesticides and eight industrial chemicals into Annex I, bringing the total to 295. As a result, EU exporters are now required to notify their intentions to export them from 1 November onwards.

READ MORE
Global Custom Synthesis & Manufacturing: Escalating Demand for Specialty Chemicals Drives Growth
News · 04/09/2023

The global custom synthesis and manufacturing market was valued at US$271.33 billion in 2022. The market value is expected to reach US$474.94 billion by 2028.

READ MORE
4 key Trends Reshaping Ocean freight Industry in 2023
News · 04/04/2023

The ocean freight industry is undergoing a massive transformation, as the technology and supply chain management tools are being improved by the day, impacting ocean freight rates.

READ MORE
What do China’s data export regulations mean for its trade competitiveness?
News · 13/12/2022

In the second half of 2022, China unveiled the details of its data export regulations, providing further explanations to its existing laws and regulations on data.

READ MORE
Energy Crisis: The EU Chemical Industry Is Reaching Breaking Point
News · 11/11/2022

The current energy crisis has reached an unsustainable level for the European chemical industry. For the first time ever, the EU imports more chemicals than it exports, both in volume and value, resulting in a trade deficit of € 5.6 bn for the first half of 2022.

READ MORE
European Union proposes to add two new hazard classes to EU CLP regulation for endocrine disruptors (EDCs)
News · 17/10/2022

Endocrine Disrupting Chemicals (also referred to as hormone disruptors or EDCs) are synthetic chemicals that are not produced by the human body and that disrupt the normal functioning of humans and animals.

READ MORE